tirzepatide for psoriatic arthritis π¨ First-of-its-kind Phase 3b data: treating obesity improves outcomes Today, Eli Lilly and Company announced positive topline results from TOGETHER-PsA, the first controlled trial evaluating an incretin therapy used alongside TOGETHER-PsO phase IIIb: Ixekizumab Β±
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 2 - Sep 7


























